Comparative analysis of bevacizumab and sorafenib on the survival of retinal ganglion cells in the treatment of retinal diseases
Sci Rep. 2025 Aug 5;15(1):28587. doi: 10.1038/s41598-025-12199-w. ABSTRACT This study investigates the effects of bevacizumab, a common vascular endothelial growth factor (VEGF) inhibitor, in treating …